Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Elanco Animal Health Raises FY2025 Adj EPS Guidance from $0.85-$0.91 to $0.91-$0.94 vs $0.90 Est; Raises FY2025 Sales Guidance from $4.570B-$4.620B to $4.645B-$4.670B vs $4.603B Est

Author: Benzinga Newsdesk | November 05, 2025 06:30am

Financial Guidance

Elanco is updating financial guidance for the full year 2025, summarized in the following table.

2025 Full Year

(dollars in millions, except per share amounts)



 

August

Guidance



 

November

Guidance



 


 


 


 


 


 


 


 


 
Revenue

 
$4,570to$4,620

 
$4,645to$4,670
Reported Net Loss

 
$(38)to$(14)

 
$(56)to$(41)
Adjusted EBITDA

 
$850to$890

 
$880to$900
Reported Loss per Share

 
$(0.08)to$(0.03)

 
$(0.11)to$(0.08)
Adjusted Earnings per Share

 
$0.85to$0.91

 
$0.91to$0.94

Posted In: ELAN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist